Who invested in Neuronetics?
Neuronetics's investors include InterWest Partners, New Leaf Venture Partners, ONSET Ventures, Pfizer and Three Arch Partners, and 18 more on record.

United States · Series G startup
Funding summaryUpdated 26 Oct 2026
$110Mraised across 6 rounds since 2001, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $15M sold, first sale Jun 2017
From a historical funding recordSEC filing: $34M sold, first sale Apr 2015
No investor was named in the report.
Reported by sec.govSEC filing: $272K sold, first sale Dec 2012
Reported by marketwire.comSEC filing: $30M sold, first sale May 2011
Reported by onbiovc.comSEC filing: $30M sold, first sale Aug 2009
From a historical funding record
From the SEC filings it signed: 6 on the team.
On the board, as filediBrian FarleyRon HuntStephen CampeWilfred Jaeger
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Neuronetics's investors include InterWest Partners, New Leaf Venture Partners, ONSET Ventures, Pfizer and Three Arch Partners, and 18 more on record.
Neuronetics has raised $110M across 6 rounds since 2001. One round did not disclose an amount, so the total is a floor.
Neuronetics's most recent round was a Series G of $15M in Jun 2017.
Neuronetics's largest round on record is $34M (Series F), in Apr 2015.
Neuronetics's first round on record, in Aug 2001, was backed by Accuitive Medical Ventures and Partisan Management Group.
Neuronetics's latest named round is a Series G, in Jun 2017.
Neuronetics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.